We are delighted to present the anniversary Research Topic, “16 Years with Frontiers in Oncology.” This milestone collection celebrates the groundbreaking ...

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...

When seven-month-old Evelyn was diagnosed with a rare cancer, her mother was told proton beam therapy would be her daughter's ...

A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative ...

The first ever immunotherapy treatment for a rare form of aggressive head and neck cancer causing facial disfigurement has ...

According to Precedence Research, the global oncology market size was valued at USD 250.88 billion in 2025 and will grow from ...

Immunotherapy-chemotherapy combination of eftilagimod alfa (efti) and paclitaxel led to strong objective response rates and ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

The global T-Cell lymphoma therapeutics market size was valued at US$ 2.3 Bn in 2024 and is projected to reach US$ 5.7 Bn by ...

Melbourne man Ralph Markham’s life was transformed by love and, later, a devastating cancer diagnosis. Now, he is hoping new ...